Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical

NICE Launches Clinical Guidelines Website In Anticipation Of New Role

  • News

Executive Summary

The U.K.’s National Institute for Health and Clinical Excellence launched a new section within its website dedicated to providing health care providers with evidence-based guidelines. The addition comes in anticipation of the proposed change in NICE’s role, which would emphasize promoting best practices rather than determining the cost-effectiveness of drugs.

You may also be interested in...



HHS Plans To Use Four Primary Sources For Online Comparative Effectiveness Research Inventory

Details regarding the inventory are revealed in a Federal Register notice posted by HHS' Office of the Assistant Secretary for Planning and Evaluation.

Online Inventory Of Comparative Effectiveness Research Launched By PIPC

The Partnership to Improve Patient Care launched a new online inventory of federally funded comparative effectiveness research projects.

NICE Likely To Lose Cost-Watchdog Status By 2013

The U.K.'s National Institute for Clinical Excellence (NICE) will likely no longer have any role in drug cost-effectiveness decisions after 2013, according to officials.

Table

View full table

Topics

Tags:
BioPharmaceutical
UsernamePublicRestriction

Register

LL009864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By